Prognostic value of serum copeptin level in patients with subarachnoid haemorrhage
DOI:
https://doi.org/10.14739/2310-1237.2018.3.151867Keywords:
subarachnoid hemorrhage, prognosisAbstract
Subarachnoid haemorrhage (SAH) is one of the most common forms of intracranial vascular pathology and one of the severest types of cerebral circulation disorders. According to epidemiology, up to 5000 cases of SAH of an aneurysmal genesis occur annually in Ukraine with an average incidence of 12 cases / 100.000 / year per 45 million people.Purpose of the study. Evaluation of diagnostic informativeness of сopeptin serum values in determining the risk of complications in patients with subarachnoid hemorrhage.
Materials and methods. A prospective, cohort study of 82 patients (40 men and 42 women, mean age 49.6 ± 1.3 years) was conducted. The diagnosis was made on the basis of clinical neuroimaging criteria. Aneurysmal genesis of SAH according to cerebral angiography was verifid in 58 (71.9 %). Serum copeptin level was determined on the 3rd day of the disease by ELISA. The development of a complex of SAH complications in the form of secondary ischemia and cerebral angiospasm was considered as the primary end point. The threshold value of serum concentration of copeptin in the assessment of the
risk of the development of SAH complications was determined by the results of ROC analysis.
Results. The combination of SAH complications was diagnosed in 27 (32.9 %) patients, while the serum level of copeptin in this subcohort was signifiantly higher than that in the group of patients without complications by 44.2 % 0.738 (0.667–0.800) ng / ml versus 0.419 (0.347–0.549), P ˂ 0.01). The serum level of copeptin ≥0.605 ng / ml was found to be associated with
an increase in the cumulative risk of SAH complications by 9.5 times (95 % CI 3.6–24.8, P ˂ 0.0001; AUC = 0.95 ± 0.02 95 % CI 0.90-0.99, P = 0.001; diagnostic accuracy is 85.4 %; sensitivity – 85.2 %, specifiity – 85.5 %).
Conclusion. The serum level of copeptin is a highly informative marker for the detection of individual cumulative risk of complications in patients with SAH.
References
Ziai, W., Carhuapoma, J. R., Nyquist, P., & Hanley, D. F. (2017). Erratum: Medical and Surgical Advances in Intracerebral Hemorrhage and Intraventricular Hemorrhage. Semin Neurol, 37(1), 103–104. doi: 10.1055/s-0037-1598083.
Pedachenko, E. G., Huk, A. P., & Nikiforova, A. N. (2017). Nejrokhirurgicheskaya pomoshh' pri cerebrovaskulyarnykh boleznyakh v Ukraine. Analiz statisticheskikh dannykh nejrokhirurgicheskoj sluzhby [Neurosurgical care in cerebrovascular diseases in Ukraine. Analysis of statistical data of neurosurgical service]. Ukrainskyi neirokhirurhichnyi zhurnal, 1, 33–39 [in Russian].
Zozulya, I. S., Golovchenko, Yu. I., Zozulya, A. I., Onoprienko, O. P., & Volosovets, A. O. (2015). Osnovni pryntsypy diahnostyky, formuvannia diahnozu, likuvannia ta profilaktyky mozkovoho insultu [General principles of diagnostic, forming of diagnosis, treatment and prediction of stroke]. Ukrainskyi medychnyi chasopys, 5, 34–38. [in Ukrainian].
Voloshyn, P. V., & Maruta, N. O. (2017). Osnovni napriamky naukovykh rozrobok v nevrolohii, psykhiatrii ta narkolohii v Ukraini [The main directions for scientifi c developments in the fi elds of neurology, psychiatry and narcology in Ukraine]. Ukrayinskyi visnyk psykhonevrolohii, 25(1), 10–18. [in Ukrainian].
Cusack, T. J., Carhuapoma, J. R., & Ziai, W. C. (2018). Update on the Treatment of Spontaneous Intraparenchymal Hemorrhage: Medical and Interventional Management. Curr Treat Options Neurol, 20(1), 1. doi: 10.1007/s11940-018-0486-5.
Neidert, M. C., Maldaner, N., Stienen, M. N., Roethlisberger, M., Zumofen, D. W., & D'Alonzo. D. (2018). The Barrow Neurological Institute Grading Scale as a Predictor for Delayed Cerebral Ischemia and Outcome After Aneurysmal Subarachnoid Hemorrhage: Data From a Nationwide Patient Registry (Swiss SOS). Neurosurgery, 83(6), 1286–1293. doi: 10.1093/neuros/nyx609.
De Marchis, G. M., Katan, M., Barro, C., Fladt, J., Traenka, C., Seiffge, D. J., et al. (2018). Serum neurofilament light chain in patients with acute cerebrovascular events. Eur J Neurol, 25(3), 562–568. doi: 10.1111/ene.13554.
Aksu, F., Gurger, M., Yilmaz, M., Atescelik, M., Yildiz, M., Ilhan, N., et al. (2016). Copeptin Levels in Cerebral Infarction, Intracranial Hemorrhage and Subarachnoid Hemorrhage. Clin Lab, 62(12), 2387–2393. doi: 10.7754/Clin.Lab.2016.160532.
Tamargo, R. J. (2012). Copeptin in aneurysmal subarachnoid hemorrhage. Crit Care, 16(1), 103. doi: 10.1186/cc10594.
Sugimoto, K., Inamasu, J., Kato, Y., Yamada, Y., Ganaha, T., Oheda, M., et al. (2013). Association between elevated plasma norepinephrine levels and cardiac wall motion abnormality in poor-grade subarachnoid hemorrhage patients. Neurosurgical Review, 36(2), 259–266. doi: 10.1007/s10143-012-0424-z.
Niesten, J. M., van der Schaaf, I. C., Biessels, G. J., van Otterloo, A. E., van Seeters, T., Horsch, A. D., et al. (2013). Relationship between thrombus attenuation and different stroke subtypes. DUtch acute Stroke Trial (DUST). Neuroradiology, 55(9), 1071–1079. doi: 10.1007/s00234-013-1217-y.
Schmidt, J. M., Crimmins, M., Lantigua, H., Fernandez, A., Zammit, C., Falo, C., et al. (2014). Prolonged elevated heart rate is a risk factor for adverse cardiac events and poor outcome after subarachnoid hemorrhage. Neurocritical Care, 20(3), 390–398. doi: 10.1007/s12028-013-9909-z.
Yoneda, H., Nakamura, T., Shirao, S., Tanaka, N., Ishihara, H., Suehiro, E., et al. (2013). Multicenter prospective cohort study on volume management after subarachnoid hemorrhage: Hemodynamic changes according to severity of subarachnoid hemorrhage and cerebral vasospasm. Stroke, 44(8), 2155–2161. doi: 10.1161/STROKEAHA.113.001015.
Li, M. H., Chen, S. W., Li, Y. D., Chen, Y. C., Cheng, Y. S., Hu, D. J., et al. (2013). Prevalence of unruptured cerebral aneurysms in Chinese adults aged 35 to 75 years: a cross-sectional study. Annals of Internal Medicine, 159(8), 514–521. doi: 10.7326/0003-4819-159-8-201310150-00004.
Kingwell, K. (2014). Stroke: improving the management of patients at risk of haemorrhagic stroke. Nature Reviews Neurology, 10(1), 1–13.
Fernandez, S. J., Barakat, I., Ziogas, J., Frugier, T., Stylli, S. S., Laidlaw, J. D. et al. (2018). Association of copeptin, a surrogate marker of arginine vasopressin, with cerebral vasospasm and delayed ischemic neurologic deficit after aneurysmal subarachnoid hemorrhage. Neurosurg, 1–7. doi: 10.3171/2017.10.JNS17795.
Fung, C., Inglin, F., Murek, M., Balmer, M., Abu-Isa, J., Z'Graggen, W. J., et al. (2016). Reconsidering the logic of World Federation of Neurosurgical Societies grading in patients with severe subarachnoid. J Neurosurg, 124(2), 299–304. doi: 10.3171/2015.2.JNS14614.
Naval, N. S., Chang, T., Caserta, F., Kowalski, R. G., Carhuapoma, J. R., & Tamargo, R. J. (2012). Impact of pattern of admission on outcomes after aneurysmal subarachnoid hemorrhage. J Crit Care, 27(5), 532.e 1–7. doi: 10.1016/j.jcrc.2012.03.006.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
